| Financial Year |
March 31 2023 |
| Monetary Funds |
170,264,693.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
131,003,670.35 |
| Advances to Suppliers |
15,104,310.43 |
| Other Receivables |
5,666,617.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
172,990,253.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,791,666.13 |
| Total Current Assets |
533,178,938.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
193,661,579.72 |
| Under-construction Projects |
61,101,303.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,776,879.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
503,144.64 |
| Deferred Income Tax Assets |
5,528,600.32 |
| Other Non-Current Assets |
3,055,254.30 |
| Sub-Total of Non-Current Assets |
337,789,656.36 |
| Total Assets |
870,968,594.56 |
| Short-Term Loans |
5,420,414.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
88,488,260.00 |
| Accounts Payable |
78,738,673.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,085,381.97 |
| Taxes Payable |
5,334,517.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,863,453.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,239,305.17 |
| Other Current Liabilities |
7,783,868.14 |
| Sub-Total of Current Liabilities |
264,663,460.21 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
931,005.98 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,381,951.27 |
| Total Liabilities |
276,045,411.48 |
| Paid-In Capital(Or Share Stock) |
81,752,500.00 |
| Capital Surplus |
176,125,526.61 |
| Surplus Reserve |
42,029,419.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
286,510,791.04 |
| Minority Stockholder's Interest |
8,522,175.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
586,401,007.97 |
| Owner's Equity（Stockholder's Equity） |
594,923,183.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
870,968,594.56 |
